Full Text View
Tabular View
No Study Results Posted
Related Studies
Investigation of the Drug Dimethoxbenzylidene Anabaseine in Treating Schizophrenia Patients
This study is currently recruiting participants.
Study NCT00255918   Information provided by National Institute of Mental Health (NIMH)
First Received: November 16, 2005   Last Updated: March 9, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Schizophrenia
Psychotic Disorders
More general conditions related to this trial
Mental Disorders
Schizophrenia and Disorders with Psychotic Features
Interventions listed in this trial
Placebo
Additional drug interventions recognized in this trial
3-(2,4-dimethoxybenzylidene)anabaseine
More general drug interventions related to this trial
Cholinergic Agents
Cholinergic Agonists
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Nicotinic Agonists
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
National Institute of Mental Health (NIMH)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services